320 related articles for article (PubMed ID: 31926377)
1. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
Li Y; Wang KN; He L; Ji LN; Mao ZW
J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
[TBL] [Abstract][Full Text] [Related]
2. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
4. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
[TBL] [Abstract][Full Text] [Related]
5. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents.
Li Y; Tan CP; Zhang W; He L; Ji LN; Mao ZW
Biomaterials; 2015 Jan; 39():95-104. PubMed ID: 25477176
[TBL] [Abstract][Full Text] [Related]
6. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
Qin WW; Pan ZY; Cai DH; Li Y; He L
Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
[TBL] [Abstract][Full Text] [Related]
7. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
8. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
[TBL] [Abstract][Full Text] [Related]
9. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
10. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
12. Phenoxide chelated Ir(iii) N-heterocyclic carbene complexes: synthesis, characterization, and evaluation of their in vitro anticancer activity.
Zhang Y; Zhang S; Tian Z; Li J; Xu Z; Li S; Liu Z
Dalton Trans; 2018 Oct; 47(39):13781-13787. PubMed ID: 30238113
[TBL] [Abstract][Full Text] [Related]
13. Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex.
Zhang J; Liu J; Liu X; Liu B; Song S; He X; Che C; Si M; Yang G; Liu Z
J Inorg Biochem; 2020 Jun; 207():111063. PubMed ID: 32222581
[TBL] [Abstract][Full Text] [Related]
14. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
Negi M; Dixit T; Venkatesh V
Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
[TBL] [Abstract][Full Text] [Related]
15. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
16. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
17. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
[TBL] [Abstract][Full Text] [Related]
18. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
[TBL] [Abstract][Full Text] [Related]
19. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
Ye RR; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2016 Aug; 45(33):13042-51. PubMed ID: 27139504
[TBL] [Abstract][Full Text] [Related]
20. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
